PEVC case study: Biotech investment with a complex capital structure

Sep 30, 2020 · 25 min watch

SECTION + CREDENTIAL

EXCLUSIVE

In this real-world case study, three investors examine the valuation of a clinical-stage biotech company using three different methods. However, they arrive at similar conclusions.

Reserved for CEIV credential holders, FVS Section members, PEVC Content Subscriptions and Valuations Subscriptions

Already a CEIV credential holder, FVS Section member or PEVC Content Subscriber?

Log in with your AICPA account

Not a CEIV credential holder, FVS Section member or PEVC Content Subscriber?

Discover the benefits of AICPA membership, Certified in Entity and Intangible Valuations credential, Forensic & Valuation Services Section membership and Private Equity and Venture Capital Topic Subscriber. To gain access to exclusive content, your first step is to join the AICPA.

Learn more about Forensic & Valuation Services Section membership